 | • レポートコード：MRC309Z1732 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のトルバプタンAPIの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のトルバプタンAPI市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - トルバプタンAPIの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため トルバプタンAPI市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・純度≧99%、純度<99% 用途別セグメント ・タブレット、その他 主要な市場プレーヤー ・Extrovis AG、Aurore Life Sciences Private Ltd、Lupin Ltd、Olon Spa、Alkem Laboratories Ltd、Msn Laboratories Private Ltd、Apotex Pharmachem India Pvt Ltd、Hetero Drugs Ltd、Otsuka Pharmaceutical、Jiangsu Hengrui Pharmaceuticals Co Ltd、Zhejiang Huahai Pharmaceutical Co Ltd、Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical、Chengdu Baiyu Pharmaceutical、Sichuan Ren'an Pharmaceutical、Nanjing Chia Tai Tianqing Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、トルバプタンAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なトルバプタンAPIメーカーの企業概要、2019年～2022年までのトルバプタンAPIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なトルバプタンAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別トルバプタンAPIの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのトルバプタンAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのトルバプタンAPI市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびトルバプタンAPIの産業チェーンを掲載しています。 ・第14、15章では、トルバプタンAPIの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - トルバプタンAPIの概要 - 種類別分析（2018年vs2022年vs2029年）：純度≧99%、純度<99% - 用途別分析（2018年vs2022年vs2029年）：タブレット、その他 - 世界のトルバプタンAPI市場規模・予測 - 世界のトルバプタンAPI生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Extrovis AG、Aurore Life Sciences Private Ltd、Lupin Ltd、Olon Spa、Alkem Laboratories Ltd、Msn Laboratories Private Ltd、Apotex Pharmachem India Pvt Ltd、Hetero Drugs Ltd、Otsuka Pharmaceutical、Jiangsu Hengrui Pharmaceuticals Co Ltd、Zhejiang Huahai Pharmaceutical Co Ltd、Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical、Chengdu Baiyu Pharmaceutical、Sichuan Ren'an Pharmaceutical、Nanjing Chia Tai Tianqing Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：純度≧99%、純度<99% ・用途別分析2018年-2029年：タブレット、その他 ・トルバプタンAPIの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・トルバプタンAPIのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・トルバプタンAPIのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・トルバプタンAPIの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・トルバプタンAPIの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Tolvaptan API market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Tolvaptan API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tolvaptan API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Tolvaptan API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tolvaptan API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tolvaptan API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Extrovis AG, Aurore Life Sciences Private Ltd, Lupin Ltd, Olon Spa and Alkem Laboratories Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tolvaptan API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥99%
Purity<99%
Market segment by Application
Tablet
Others
Major players covered
Extrovis AG
Aurore Life Sciences Private Ltd
Lupin Ltd
Olon Spa
Alkem Laboratories Ltd
Msn Laboratories Private Ltd
Apotex Pharmachem India Pvt Ltd
Hetero Drugs Ltd
Otsuka Pharmaceutical
Jiangsu Hengrui Pharmaceuticals Co Ltd
Zhejiang Huahai Pharmaceutical Co Ltd
Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical
Chengdu Baiyu Pharmaceutical
Sichuan Ren'an Pharmaceutical
Nanjing Chia Tai Tianqing Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tolvaptan API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tolvaptan API, with price, sales, revenue and global market share of Tolvaptan API from 2018 to 2023.
Chapter 3, the Tolvaptan API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tolvaptan API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tolvaptan API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tolvaptan API.
Chapter 14 and 15, to describe Tolvaptan API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Tolvaptan API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tolvaptan API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥99%
1.3.3 Purity<99%
1.4 Market Analysis by Application
1.4.1 Overview: Global Tolvaptan API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tablet
1.4.3 Others
1.5 Global Tolvaptan API Market Size & Forecast
1.5.1 Global Tolvaptan API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tolvaptan API Sales Quantity (2018-2029)
1.5.3 Global Tolvaptan API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Extrovis AG
2.1.1 Extrovis AG Details
2.1.2 Extrovis AG Major Business
2.1.3 Extrovis AG Tolvaptan API Product and Services
2.1.4 Extrovis AG Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Extrovis AG Recent Developments/Updates
2.2 Aurore Life Sciences Private Ltd
2.2.1 Aurore Life Sciences Private Ltd Details
2.2.2 Aurore Life Sciences Private Ltd Major Business
2.2.3 Aurore Life Sciences Private Ltd Tolvaptan API Product and Services
2.2.4 Aurore Life Sciences Private Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Aurore Life Sciences Private Ltd Recent Developments/Updates
2.3 Lupin Ltd
2.3.1 Lupin Ltd Details
2.3.2 Lupin Ltd Major Business
2.3.3 Lupin Ltd Tolvaptan API Product and Services
2.3.4 Lupin Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Lupin Ltd Recent Developments/Updates
2.4 Olon Spa
2.4.1 Olon Spa Details
2.4.2 Olon Spa Major Business
2.4.3 Olon Spa Tolvaptan API Product and Services
2.4.4 Olon Spa Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Olon Spa Recent Developments/Updates
2.5 Alkem Laboratories Ltd
2.5.1 Alkem Laboratories Ltd Details
2.5.2 Alkem Laboratories Ltd Major Business
2.5.3 Alkem Laboratories Ltd Tolvaptan API Product and Services
2.5.4 Alkem Laboratories Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alkem Laboratories Ltd Recent Developments/Updates
2.6 Msn Laboratories Private Ltd
2.6.1 Msn Laboratories Private Ltd Details
2.6.2 Msn Laboratories Private Ltd Major Business
2.6.3 Msn Laboratories Private Ltd Tolvaptan API Product and Services
2.6.4 Msn Laboratories Private Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Msn Laboratories Private Ltd Recent Developments/Updates
2.7 Apotex Pharmachem India Pvt Ltd
2.7.1 Apotex Pharmachem India Pvt Ltd Details
2.7.2 Apotex Pharmachem India Pvt Ltd Major Business
2.7.3 Apotex Pharmachem India Pvt Ltd Tolvaptan API Product and Services
2.7.4 Apotex Pharmachem India Pvt Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Apotex Pharmachem India Pvt Ltd Recent Developments/Updates
2.8 Hetero Drugs Ltd
2.8.1 Hetero Drugs Ltd Details
2.8.2 Hetero Drugs Ltd Major Business
2.8.3 Hetero Drugs Ltd Tolvaptan API Product and Services
2.8.4 Hetero Drugs Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hetero Drugs Ltd Recent Developments/Updates
2.9 Otsuka Pharmaceutical
2.9.1 Otsuka Pharmaceutical Details
2.9.2 Otsuka Pharmaceutical Major Business
2.9.3 Otsuka Pharmaceutical Tolvaptan API Product and Services
2.9.4 Otsuka Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Otsuka Pharmaceutical Recent Developments/Updates
2.10 Jiangsu Hengrui Pharmaceuticals Co Ltd
2.10.1 Jiangsu Hengrui Pharmaceuticals Co Ltd Details
2.10.2 Jiangsu Hengrui Pharmaceuticals Co Ltd Major Business
2.10.3 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Product and Services
2.10.4 Jiangsu Hengrui Pharmaceuticals Co Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jiangsu Hengrui Pharmaceuticals Co Ltd Recent Developments/Updates
2.11 Zhejiang Huahai Pharmaceutical Co Ltd
2.11.1 Zhejiang Huahai Pharmaceutical Co Ltd Details
2.11.2 Zhejiang Huahai Pharmaceutical Co Ltd Major Business
2.11.3 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Product and Services
2.11.4 Zhejiang Huahai Pharmaceutical Co Ltd Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Zhejiang Huahai Pharmaceutical Co Ltd Recent Developments/Updates
2.12 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical
2.12.1 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Details
2.12.2 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Major Business
2.12.3 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Product and Services
2.12.4 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical Recent Developments/Updates
2.13 Chengdu Baiyu Pharmaceutical
2.13.1 Chengdu Baiyu Pharmaceutical Details
2.13.2 Chengdu Baiyu Pharmaceutical Major Business
2.13.3 Chengdu Baiyu Pharmaceutical Tolvaptan API Product and Services
2.13.4 Chengdu Baiyu Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
2.14 Sichuan Ren'an Pharmaceutical
2.14.1 Sichuan Ren'an Pharmaceutical Details
2.14.2 Sichuan Ren'an Pharmaceutical Major Business
2.14.3 Sichuan Ren'an Pharmaceutical Tolvaptan API Product and Services
2.14.4 Sichuan Ren'an Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sichuan Ren'an Pharmaceutical Recent Developments/Updates
2.15 Nanjing Chia Tai Tianqing Pharmaceutical
2.15.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
2.15.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
2.15.3 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Product and Services
2.15.4 Nanjing Chia Tai Tianqing Pharmaceutical Tolvaptan API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Tolvaptan API by Manufacturer
3.1 Global Tolvaptan API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tolvaptan API Revenue by Manufacturer (2018-2023)
3.3 Global Tolvaptan API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tolvaptan API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tolvaptan API Manufacturer Market Share in 2022
3.4.2 Top 6 Tolvaptan API Manufacturer Market Share in 2022
3.5 Tolvaptan API Market: Overall Company Footprint Analysis
3.5.1 Tolvaptan API Market: Region Footprint
3.5.2 Tolvaptan API Market: Company Product Type Footprint
3.5.3 Tolvaptan API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tolvaptan API Market Size by Region
4.1.1 Global Tolvaptan API Sales Quantity by Region (2018-2029)
4.1.2 Global Tolvaptan API Consumption Value by Region (2018-2029)
4.1.3 Global Tolvaptan API Average Price by Region (2018-2029)
4.2 North America Tolvaptan API Consumption Value (2018-2029)
4.3 Europe Tolvaptan API Consumption Value (2018-2029)
4.4 Asia-Pacific Tolvaptan API Consumption Value (2018-2029)
4.5 South America Tolvaptan API Consumption Value (2018-2029)
4.6 Middle East and Africa Tolvaptan API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tolvaptan API Sales Quantity by Type (2018-2029)
5.2 Global Tolvaptan API Consumption Value by Type (2018-2029)
5.3 Global Tolvaptan API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tolvaptan API Sales Quantity by Application (2018-2029)
6.2 Global Tolvaptan API Consumption Value by Application (2018-2029)
6.3 Global Tolvaptan API Average Price by Application (2018-2029)
7 North America
7.1 North America Tolvaptan API Sales Quantity by Type (2018-2029)
7.2 North America Tolvaptan API Sales Quantity by Application (2018-2029)
7.3 North America Tolvaptan API Market Size by Country
7.3.1 North America Tolvaptan API Sales Quantity by Country (2018-2029)
7.3.2 North America Tolvaptan API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tolvaptan API Sales Quantity by Type (2018-2029)
8.2 Europe Tolvaptan API Sales Quantity by Application (2018-2029)
8.3 Europe Tolvaptan API Market Size by Country
8.3.1 Europe Tolvaptan API Sales Quantity by Country (2018-2029)
8.3.2 Europe Tolvaptan API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tolvaptan API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tolvaptan API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tolvaptan API Market Size by Region
9.3.1 Asia-Pacific Tolvaptan API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tolvaptan API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tolvaptan API Sales Quantity by Type (2018-2029)
10.2 South America Tolvaptan API Sales Quantity by Application (2018-2029)
10.3 South America Tolvaptan API Market Size by Country
10.3.1 South America Tolvaptan API Sales Quantity by Country (2018-2029)
10.3.2 South America Tolvaptan API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tolvaptan API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tolvaptan API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tolvaptan API Market Size by Country
11.3.1 Middle East & Africa Tolvaptan API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tolvaptan API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tolvaptan API Market Drivers
12.2 Tolvaptan API Market Restraints
12.3 Tolvaptan API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tolvaptan API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tolvaptan API
13.3 Tolvaptan API Production Process
13.4 Tolvaptan API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tolvaptan API Typical Distributors
14.3 Tolvaptan API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer